Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
AFT Pharmaceuticals Ltd. ( (AU:AFP) ) has shared an announcement.
At the 2025 annual shareholder meeting of AFT Pharmaceuticals Ltd., all proposed resolutions were approved. These included the authorization for directors to set Deloitte’s fees as auditor for 2026, the re-election of Hartley Atkinson as a director, and the election of Allison Yorston as a new director. This outcome reflects strong shareholder support and positions the company for continued stability and strategic governance.
More about AFT Pharmaceuticals Ltd.
AFT Pharmaceuticals Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of pharmaceutical products. The company is known for its innovative approach to healthcare solutions and has a significant presence in the New Zealand and Australian markets.
Average Trading Volume: 2,892
Technical Sentiment Signal: Sell
Current Market Cap: A$260.5M
See more insights into AFP stock on TipRanks’ Stock Analysis page.